Brought to you by 
Nichi-Iko launches tender offer for Sagent Pharmaceuticals for $735mm; 85.6% of shares successfully tendered
08 Sep 2020
Executive Summary
Japanese pharma Nichi-Iko Pharmaceutical Co. Ltd. launched a $735mm in cash tender offer for generics company Sagent Pharmaceuticals Inc. The tender will commence in 15 business days (and remain open for a minimum of 20 days thereafter) followed by a second-step merger.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Generic Drugs
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Nichi-Iko launches tender offer for Sagent Pharmaceuticals for $735mm; 85.6% of shares successfully tendered
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice